New real-world research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) reveals that people living with multiple sclerosis (MS) face a much higher risk of being hospitalised and dying from COVID-19 than the general population.
Higher COVID-19 hospitalization and mortality rates in MS patients despite vaccination
- Post author:
- Post published:March 28, 2024
- Post category:uncategorized